Dragon (repulsive guidance molecule b) inhibits IL-6 expression in macrophages

Journal of Immunology

Volumn 186, Issue 3, 2011, Pages 1369-1376

  Xia, Yin ^a,g   Cortez Retamozo, Virna ^a   Niederkofler, Vera ^b,c   Salie, Rishard ^b,c   Chen, Shanzhuo ^a   Samad, Tarek A ^a   Hong, Charles C ^d,e   Arber, Silvia ^b,c   Vyas, Jatin M ^a   Weissleder, Ralph ^a,f   Pittet, Mikael J ^a   Lin, Herbert Y ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF BASEL   (Switzerland)

^c FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f HARVARD MEDICAL SCHOOL   (United States)

^g and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; HEMOJUVELIN; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; REPULSIVE GUIDANCE MOLECULE B; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CONTROLLED STUDY; DENDRITIC CELL; IMMUNOCOMPETENT CELL; KNOCKOUT MOUSE; LUNG PARENCHYMA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; WILD TYPE;

ANIMALS; CELL LINE; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MACROPHAGES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NERVE TISSUE PROTEINS; P38 MITOGEN-ACTIVATED PROTEIN KINASES;

EID: 79251564772     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002047     Document Type: Article

References (32)

1. Shi, Y., and J. Massagué. 2003. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 113: 685-700. (Pubitemid 36724933)
2. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, R. Allen, C. Sidman, G. Proetzel, D. Calvin, et al. 1992. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
3. Xia, Y., and A. L. Schneyer. 2009. The biology of activin: recent advances in structure, regulation and function. J. Endocrinol. 202: 1-12.
4. Vallet, S., S. Mukherjee, N. Vaghela, T. Hideshima, M. Fulciniti, S. Pozzi, L. Santo, D. Cirstea, K. Patel, A. R. Sohani, et al. 2010. Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Proc. Natl. Acad. Sci. USA 107: 5124-5129.
5. Gould, S. E., M. Day, S. S. Jones, and H. Dorai. 2002. BMP-7 regulates chemokine, cytokine, and hemodynamic gene expression in proximal tubule cells. Kidney Int. 61: 51-60.
6. Lee, M. J., C. W. Yang, D. C. Jin, Y. S. Chang, B. K. Bang, and Y. S. Kim. 2003. Bone morphogenetic protein-7 inhibits constitutive and interleukin-1 β-induced monocyte chemoattractant protein-1 expression in human mesangial cells: role for JNK/AP-1 pathway. J. Immunol. 170: 2557-2563.
7. Maric, I., L. Poljak, S. Zoricic, D. Bobinac, D. Bosukonda, K. T. Sampath, and S. Vukicevic. 2003. Bone morphogenetic protein-7 reduces the severity of colon tissue damage and accelerates the healing of inflammatory bowel disease in rats. J. Cell. Physiol. 196: 258-264.
8. Hori, M., H. Sawai, Y. Tsuji, H. Okamura, and K. Koyama. 2006. Bone morphogenetic protein-2 counterregulates interleukin-18 mRNA and protein in MC3T3-E1 mouse osteoblastic cells. Connect. Tissue Res. 47: 124-132.
9. Hagen, M., K. Fagan, W. Steudel, M. Carr, K. Lane, D. M. Rodman, and J. West. 2007. Interaction of interleukin-6 and the BMP pathway in pulmonary smooth muscle. Am. J. Physiol. Lung Cell. Mol. Physiol. 292: L1473-L1479.
10. Kwon, S. J., G. T. Lee, J. H. Lee, W. J. Kim, and I. Y. Kim. 2009. Bone morphogenetic protein-6 induces the expression of inducible nitric oxide synthase in macrophages. Immunology 128(1, Suppl.): e758-e765.
11. Hong, J. H., G. T. Lee, J. H. Lee, S. J. Kwon, S. H. Park, S. J. Kim, and I. Y. Kim. 2009. Effect of bone morphogenetic protein-6 on macrophages. Immunology 128 (1, Suppl.): e442-e450.
12. Samad, T. A., A. Rebbapragada, E. Bell, Y. Zhang, Y. Sidis, S. J. Jeong, J. A. Campagna, S. Perusini, D. A. Fabrizio, A. L. Schneyer, et al. 2005. DRAGON, a bone morphogenetic protein co-receptor. J. Biol. Chem. 280: 14122-14129.
13. Xia, Y., Y. Sidis, A. Mukherjee, T. A. Samad, G. Brenner, C. J. Woolf, H. Y. Lin, and A. Schneyer. 2005. Localization and action of Dragon (repulsive guidance molecule b), a novel bone morphogenetic protein coreceptor, throughout the reproductive axis. Endocrinology 146: 3614-3621. (Pubitemid 41058133)
14. Xia, Y., P. B. Yu, Y. Sidis, H. Beppu, K. D. Bloch, A. L. Schneyer, and H. Y. Lin. 2007. Repulsive guidance molecule RGMa alters utilization of bone morphogenetic protein (BMP) type II receptors by BMP2 and BMP4. J. Biol. Chem. 282: 18129-18140.
15. Xia, Y., J. L. Babitt, Y. Sidis, R. T. Chung, and H. Y. Lin. 2008. Hemojuvelin regulates hepcidin expression via a selective subset of BMP ligands and receptors independently of neogenin. Blood 111: 5195-5204.
16. Xia, Y., J. L. Babitt, R. Bouley, Y. Zhang, N. Da Silva, S. Chen, Z. Zhuang, T. A. Samad, G. J. Brenner, J. L. Anderson, et al. 2010. Dragon enhances BMP signaling and increases transepithelial resistance in kidney epithelial cells. J. Am. Soc. Nephrol. 21: 666-677.
17. Babitt, J. L., Y. Zhang, T. A. Samad, Y. Xia, J. Tang, J. A. Campagna, A. L. Schneyer, C. J. Woolf, and H. Y. Lin. 2005. Repulsive guidance molecule (RGMa), a DRAGON homologue, is a bone morphogenetic protein co-receptor. J. Biol. Chem. 280: 29820-29827.
18. Babitt, J. L., F. W. Huang, D. M. Wrighting, Y. Xia, Y. Sidis, T. A. Samad, J. A. Campagna, R. T. Chung, A. L. Schneyer, C. J. Woolf, et al. 2006. Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nat. Genet. 38: 531-539.
19. Samad, T. A., A. Srinivasan, L. A. Karchewski, S. J. Jeong, J. A. Campagna, R. R. Ji, D. A. Fabrizio, Y. Zhang, H. Y. Lin, E. Bell, and C. J. Woolf. 2004. DRAGON: a member of the repulsive guidance molecule-related family of neuronal- and muscle-expressed membrane proteins is regulated by DRG11 and has neuronal adhesive properties. J. Neurosci. 24: 2027-2036.
20. LaPensee, C. R., E. R. Hugo, and N. Ben-Jonathan. 2008. Insulin stimulates interleukin-6 expression and release in LS14 human adipocytes through multiple signaling pathways. Endocrinology 149: 5415-5422.
21. Andriopoulos, B., Jr., E. Corradini, Y. Xia, S. A. Faasse, S. Chen, L. Grgurevic, M. D. Knutson, A. Pietrangelo, S. Vukicevic, H. Y. Lin, and J. L. Babitt. 2009. BMP6 is a key endogenous regulator of hepcidin expression and iron metabolism. Nat. Genet. 41: 482-487.
22. Niederkofler, V., R. Salie, M. Sigrist, and S. Arber. 2004. Repulsive guidance molecule (RGM) gene function is required for neural tube closure but not retinal topography in the mouse visual system. J. Neurosci. 24: 808-818. (Pubitemid 38146591)
23. Cuny, G. D., P. B. Yu, J. K. Laha, X. Xing, J. F. Liu, C. S. Lai, D. Y. Deng, C. Sachidanandan, K. D. Bloch, and R. T. Peterson. 2008. Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. Bioorg. Med. Chem. Lett. 18: 4388-4392.
24. Yu, P. B., H. Beppu, N. Kawai, E. Li, and K. D. Bloch. 2005. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells. J. Biol. Chem. 280: 24443-24450.
25. Zhou, Q., J. Heinke, A. Vargas, S. Winnik, T. Krauss, C. Bode, C. Patterson, and M. Moser. 2007. ERK signaling is a central regulator for BMP-4 dependent capillary sprouting. Cardiovasc. Res. 76: 390-399.
26. Nojima, J., K. Kanomata, Y. Takada, T. Fukuda, S. Kokabu, S. Ohte, T. Takada, T. Tsukui, T. S. Yamamoto, H. Sasanuma, et al. 2010. Dual roles of smad proteins in the conversion from myoblasts to osteoblastic cells by bone morphogenetic proteins. J. Biol. Chem. 285: 15577-15586.
27. Sieber, C., J. Kopf, C. Hiepen, and P. Knaus. 2009. Recent advances in BMP receptor signaling. Cytokine Growth Factor Rev. 20: 343-355.
28. Takahashi, M., F. Otsuka, T. Miyoshi, H. Otani, J. Goto, M. Yamashita, T. Ogura, H. Makino, and H. Doihara. 2008. Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation. J. Endocrinol. 199: 445-455.
29. Yamaguchi, K., S. Nagai, J. Ninomiya-Tsuji, M. Nishita, K. Tamai, K. Irie, N. Ueno, E. Nishida, H. Shibuya, and K. Matsumoto. 1999. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J. 18: 179-187.
30. Wang, P., N. Li, J. S. Li, and W. Q. Li. 2002. The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity. World J. Gastroenterol. 8: 531-536.
31. Lieskovska, J., D. Guo, and E. Derman. 2002. IL-6-overexpression brings about growth impairment potentially through a GH receptor defect. Growth Horm. IGF Res. 12: 388-398.
32. Lieskovska, J., D. Guo, and E. Derman. 2003. Growth impairment in IL-6-overexpressing transgenic mice is associated with induction of SOCS3 mRNA. Growth Horm. IGF Res. 13: 26-35.